EP Patent

EP0954283B1 — Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation

Assigned to Battelle Memorial Institute Inc · Expires 2007-03-21 · 19y expired

What this patent protects

A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.

USPTO Abstract

A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.

Drugs covered by this patent

Patent Metadata

Patent number
EP0954283B1
Jurisdiction
EP
Classification
—
Expires
2007-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Battelle Memorial Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.